Kimmtrak Disease Interactions
There are 2 disease interactions with Kimmtrak (tebentafusp).
Tebentafusp (applies to Kimmtrak) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Tebentafusp has not been studied in patients with moderate to severe liver dysfunction; caution is recommended in these patients. Because increases in ALT or AST have been observed in patients treated with tebentafusp, ALT, AST, and total blood bilirubin should be monitored before starting and during treatment with tebentafusp.
Tebentafusp (applies to Kimmtrak) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
Tebentafusp has not been studied in patients with severe renal dysfunction (CrCl less than 30 mL/min); caution is recommended in these patients.
Switch to professional interaction data
Kimmtrak drug interactions
There are 309 drug interactions with Kimmtrak (tebentafusp).
Report options
More about Kimmtrak (tebentafusp)
- Kimmtrak consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
